1 year return (CAGR)
-6.21%
Arbutus Biopharma Corp Exchange (NASDAQ, USD)
ABUS
4.23
+0.01 (+0.24%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
31.98%
5 year return (CAGR)
0.14%
10 year return (CAGR)
2.45%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
837.99M
Price/Sales
4.61
Ent value
834.11M
Price/Book
3.24
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
5.48
PEG
-
Forward P/E
-
EPS growth
-26.95%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 4.24 |
| Daily high | 4.28 |
| Daily low | 4.15 |
| Daily Volume | 1.96M |
| All-time high | 30.94 |
| 1y analyst estimate | 5.36 |
| Beta | 0.62 |
| EPS (TTM) | 0.78 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 26 Feb 2026 |
Downside potential
Loading...
Downside potential data
| ABUS | S&P500 | |
| Current price drop from All-time high | -86.33% | -1.62% |
| Highest price drop | -97.19% | -56.47% |
| Date of highest drop | 9 Oct 2019 | 9 Mar 2009 |
| Avg drop from high | -75.63% | -10.66% |
| Avg time to new high | 143 days | 12 days |
| Max time to new high | 3172 days | 1805 days |
News
